Efficacy of Pioglitazone and Glimepiride Combination Therapy in Treating Subjects With Type 2 Diabetes Mellitus.
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of pioglitazone, once daily (QD), and
glimepiride combination therapy compared to glimepiride monotherapy in subjects with Type 2
Diabetes.